Form 4 for IT Gartner
Accepted 2025-12-02 00:00:00 ET · period of report 2025-11-28 · accession 0000749251-25-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-02 | 2025-11-28 | IT | Herkes Claire | EVP, Conferences | F - Tax | $232.74 | -316 | 4,441 | -7% | -$73.5K |
| D | 2025-12-02 | 2025-11-28 | IT | Herkes Claire | EVP, Conferences | M - OptEx | $180.64 | +3,052 | 7,126 | +75% | +$551.3K |
| D | 2025-12-02 | 2025-11-28 | IT | Herkes Claire | EVP, Conferences | D - Sale to Iss | $232.74 | -2,369 | 4,757 | -33% | -$551.4K |
| D | 2025-12-02 | 2025-11-28 | IT | Herkes Claire | EVP, Conferences | M - OptEx | $0.00 | -3,052 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-28 | F | D | 316 | $232.74 | 4,441 | D | — | — | (F3) Represents shares withheld for the payment of applicable income and payroll withholding taxes. |
| 2 | Common | Common Stock | 2025-11-28 | M | A | 3,052 | $180.64 | 7,126 | D | — | — | (F1) Represents shares acquired upon exercise of SARs. |
| 3 | Common | Common Stock | 2025-11-28 | D | D | 2,369 | $232.74 | 4,757 | D | — | — | (F2) Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs. |
| 4 | Derivative | Stock Appreciation Rights | 2025-11-28 | M | D | 3,052 | $0.00 | 0 | D | $180.64 · 2022-02-10 to 2028-02-10 | 3,052 Common Stock | (F4) These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 10, 2022, and are fully exercisable. |